Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5–11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial

Objective: To evaluate immunogenicity and safety of heterologous COVID-19 primary vaccination regimens of CoronaVac with fractional and standard BNT162b2 dosages in 5–11-year-old Thai children. Methods: This prospective, multicenter, double-blind, randomized control trial divided participants 1:1:1:...

Full description

Saved in:
Bibliographic Details
Main Author: Wittawatmongkol O.
Other Authors: Mahidol University
Format: Article
Published: 2023
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/89998
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University